Regulatory Open Forum

 View Only
  • 1.  Taiwan Drafts UDI Requirements for Medical Devices

    Posted 12-Jan-2021 17:02

    Five years after Taiwan first urged medical device manufacturers to include unique identification (UDI) codes on the labels of their products, regulators are seeking public consultation on making the voluntary labeling protocols mandatory.

    The draft requirements would mandate UDI labels include a host of identifiers, including license and serial numbers, license type and expiration date, batch numbers, and date of manufacture. Under the guidelines, the UDI labels would be carried on the actual package or body of Class II and Class III medical devices, or on the smallest unit of the device available for sale.

    In addition, manufacturers would need to upload the same information to the medical device identification system database of the Taiwan Food and Drug Administration (TFDA).

    Devices exempt from the draft requirements include personalized devices and single-use non-implantable in vitro diagnostic medical equipment.

    Feedback on the draft requirements is being sought by the TFDA until Jan. 4.



    ------------------------------
    Ames Gross
    President
    Pacific Bridge Medical
    Bethesda, MD
    www.pacificbridgemedical.com
    contact@pacificbridgemedical.com
    ------------------------------


  • 2.  RE: Taiwan Drafts UDI Requirements for Medical Devices

    Posted 13-Jan-2021 12:46
    Edited by Emilia Spallanzani 13-Jan-2021 12:47
      |   view attached
    To complement Ames information here the planned transition timelines:
    • Class III implantable devices –> June 1, 2021.
    • Class III non-implantable devices –> June 1, 2022.
    • Class II devices –> June 1, 2023.
    • Class I –> exempted.
    Attached the draft of the regulation (in Chinese).
    Best regards,

    ------------------------------
    Emilia Spallanzani
    QA&RA Manager
    Paul Hartmann AG
    Germany
    ------------------------------